AIRNA, a biotech company pioneering RNA editing therapeutics has closed an oversubscribed US$155m Series B financing. Headquartered in the US, AIRNA has research operations in Germany Financing was led by Venrock…
Germany: AIRNA raises oversubscribed US$155m Series B
…
…






